JPM Thematics - Genetic Therapies A Fonds
91,29
EUR
+2,35
EUR
+2,64
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,31% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 3,18% |
| Amgen Inc | US0311621009 | 3,12% |
| Novartis AG Registered Shares | CH0012005267 | 3,08% |
| Biomarin Pharmaceutical Inc | US09061G1013 | 3,04% |
| Ionis Pharmaceuticals Inc | US4622221004 | 3,02% |
| Gilead Sciences Inc | US3755581036 | 3,02% |
| Biogen Inc | US09062X1037 | 2,97% |
| Roche Holding AG | CH0012032048 | 2,96% |
| CRISPR Therapeutics AG | CH0334081137 | 2,91% |
| Sonstige | 69,38% |